What Makes the SOHO Annual Meeting Unique?

By Leah Sherwood - Last Updated: February 1, 2023

Guillermo Garcia-Manero, MD, of the Department of Leukemia at the MD Anderson Cancer Center, explains what he thinks makes the SOHO Annual Meeting stand out.

Post Tags:SOHO 2022

Unpacking the COA Prescription for Health Care Reform: What Does it Mean for Patients and Oncologists?

Melissa BadamoAcute Lymphoblastic Leukemia | April 23, 2025

The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.

NCI Enters Research Cooperative Agreement to Advance Oral Agent for Acute Leukemia, Other Cancers

Andrew MorenoAcute Myeloid Leukemia | April 22, 2025

The investigational small molecule enzomenib has received FDA Orphan Drug and Fast Track designations in AML.

New Clinical Trial to Evaluate GPC-100 for the Treatment of AML

Melissa BadamoAcute Myeloid Leukemia | April 17, 2025

GPC-100 is a a small molecule CXCR4 inhibitor that showed promising preclinical activity in combination with cytarabine.

NCCN Foundation Announces 2025 Young Investigator Award Recipients

Melissa BadamoPrint | April 14, 2025

The award provides early-career researchers at NCCN Member Institutions with $150,000 in funding to support cancer research.

What Is the Role of Palliative Care for Patients With Hematologic Malignancies?

Melissa BadamoVideo Insights | April 15, 2025

Nicholas Freedman, DO, presented on symptom management and supportive care at the Tri-State Blood Cancer Conference.

What Makes the SOHO Annual Meeting Unique?

Related Posts